Share on LinkedInShare on LinkedIn

ARTICLE · 23 JUNE 2004

Regulatory Trends in the Courts: What’s New and What’s Coming

Torys
Torys
Contributor
Torys

Torys

Torys LLP is an international business law firm that works with clients who expect the best advice...

View firm profile
Explore more from Torys

A vital prerequisite to marketing biologics, pharmaceutical and medical devices in Canada is successfully completing the product approval process.

CanadaLitigation, Mediation & Arbitration

Published in gordongroup's BIOTECanada Insights, Spring 2004.

A vital prerequisite to marketing biologics, pharmaceutical and medical devices in Canada is successfully completing the product approval process. Two emerging trends from the courts may make the approval process even more important. Health Canada’s approval of drugs and devices has formed the basis of both claims and defences in recent product liability actions. These cases suggest that regulatory misstatements might be recognized by the courts as a basis for claims in negligence. On the other hand, a defence of regulatory approval might in some circumstances be available. Significant changes—both positive and negative—could be in store for companies making these products, should these claims and defences be recognized by the courts.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from